Last reviewed · How we verify
treatment of covid 19 in adults and pediatric patients 12 years of age and older who are at high risk of progression to severe covid 19 including those who are hospitalized due to covid 19 or who have mild to moderate covid 19 with at least one risk factor for progression to severe covid 19 e g older age certain chronic medical conditions
Approved treatments
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- treatment of covid 19 in adults and pediatric patients 12 years of age and older who are at high risk of progression to severe covid 19 including those who are hospitalized due to covid 19 or who have mild to moderate covid 19 with at least one risk factor for progression to severe covid 19 e g older age certain chronic medical conditions patent landscape — cliff calendar, originator estates, attackable patents
- treatment of covid 19 in adults and pediatric patients 12 years of age and older who are at high risk of progression to severe covid 19 including those who are hospitalized due to covid 19 or who have mild to moderate covid 19 with at least one risk factor for progression to severe covid 19 e g older age certain chronic medical conditions treatment landscape brief
- treatment of covid 19 in adults and pediatric patients 12 years of age and older who are at high risk of progression to severe covid 19 including those who are hospitalized due to covid 19 or who have mild to moderate covid 19 with at least one risk factor for progression to severe covid 19 e g older age certain chronic medical conditions treatment updates RSS
Related
- Treatment landscape: treatment of covid 19 in adults and pediatric patients 12 years of age and older who are at high risk of progression to severe covid 19 including those who are hospitalized due to covid 19 or who have mild to moderate covid 19 with at least one risk factor for progression to severe covid 19 e g older age certain chronic medical conditions patent cliff · treatment of covid 19 in adults and pediatric patients 12 years of age and older who are at high risk of progression to severe covid 19 including those who are hospitalized due to covid 19 or who have mild to moderate covid 19 with at least one risk factor for progression to severe covid 19 e g older age certain chronic medical conditions CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing